Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276

Watchlist Manager
Jiangsu Hengrui Pharmaceuticals Co Ltd Logo
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Watchlist
Price: 48.27 CNY -4.34% Market Closed
Market Cap: 306.5B CNY
Have any thoughts about
Jiangsu Hengrui Pharmaceuticals Co Ltd?
Write Note

Relative Value

The Relative Value of one Jiangsu Hengrui Pharmaceuticals Co Ltd stock under the Base Case scenario is 40.39 CNY. Compared to the current market price of 48.27 CNY, Jiangsu Hengrui Pharmaceuticals Co Ltd is Overvalued by 16%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
40.39 CNY
Overvaluation 16%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
58
vs Industry
13
Median 3Y
11.8
Median 5Y
12.8
Industry
2.5
Forward
11.3
vs History
71
vs Industry
6
Median 3Y
62.8
Median 5Y
68.9
Industry
21.9
Forward
51.6
vs History
82
vs Industry
15
Median 3Y
69.4
Median 5Y
87.5
Industry
16.5
vs History
80
vs Industry
14
Median 3Y
111.2
Median 5Y
118
Industry
23.6
vs History
50
vs Industry
10
Median 3Y
7.1
Median 5Y
7.7
Industry
2.1
vs History
58
vs Industry
13
Median 3Y
11
Median 5Y
12
Industry
2.6
Forward
10.4
vs History
61
vs Industry
14
Median 3Y
13
Median 5Y
14.1
Industry
5.2
vs History
79
vs Industry
6
Median 3Y
60.3
Median 5Y
66.8
Industry
13.3
Forward
42
vs History
79
vs Industry
7
Median 3Y
60.3
Median 5Y
66.8
Industry
16.6
Forward
45.3
vs History
82
vs Industry
15
Median 3Y
64.3
Median 5Y
83.5
Industry
15.6
vs History
73
vs Industry
13
Median 3Y
82.3
Median 5Y
102.8
Industry
19.1
vs History
49
vs Industry
9
Median 3Y
11.4
Median 5Y
12.7
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Jiangsu Hengrui Pharmaceuticals Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
307.9B CNY 11.8 56.5 48.8 48.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7

See Also

Discover More
Back to Top